DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Concord Biotech Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·21 Aug 2026, 4:49 am

Concord Biotech

Concord Biotech Limited has informed stock exchanges about an upcoming meeting with analysts and institutional investors. This scheduled event allows the company's management to present its current business strategy, financial performance, and future outlook directly to the investment community.

For investors, this update is significant as it provides a platform for management to address market questions and potentially share insights into upcoming projects. It offers a direct channel to gauge management's confidence and clarity on the company's growth trajectory.

Investors should watch for the company's commentary on its expansion plans, particularly in its fermentation and bio-sciences segments. Any guidance provided during the meeting could offer valuable signals regarding the company's near-term performance and operational focus.